Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial

Rangaka, MX; Hamada, Y; Duong, T; Bern, H; Calvert, J; Francis, M; Clarke, AL; Ghanouni, A; Layton, C; Hack, V; Owen-Powell, E; Surey, J; Sanders, K; Booth, HL; Crook, A; Griffiths, C; Horne, R; Kunst, H; Lipman, M; Mandelbaum, M; White, PJ; Zenner, D; Abubakar, I

Journal article

Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial

Abstract:: Objectives: To review the evidence that migrants from tuberculosis (TB) high-incidence countries migrating to TB low-incidence countries significantly contribute to active TB cases in the counties of destination, primarily through reactivation of latent TB. / Methods: This is a narrative review. The different screening programs in the countries of destination are reviewed either based on screening and preventive treatment of latent TB pre or more commonly – post arrival. / Results: Screening can be performed using interferon-gamma release assays (IGRA) or tuberculin skin tests (TST). Preventive treatment of latent TB is using either monotherapy with isoniazid, or in combination with rifampicin or rifapentine. We discuss the ethical issues of preventive treatment in asymptomatic individuals and how these are addressed in different screening programs. / Conclusion: Screening migrants from TB high endemic countries to TB low endemic countries is beneficial. There is a lack of standardization and agreement on screening protocols, follow up and treatment

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Rangaka, M. X., Hamada, Y., Duong, T., Bern, H., Calvert, J., Francis, M., Clarke, A. L., Ghanouni, A., Layton, C., Hack, V., Owen-Powell, E., Surey, J., Sanders, K., Booth, H. L., Crook, A., Griffiths, C., Horne, R., Kunst, H., Lipman, M., … Abubakar, I. (2022). Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial. BMJ Open, 12(9), e057717–e057717.

MLA Style

Rangaka, MX, et al. “Evaluating the Effect of Short-Course Rifapentine-Based Regimens with or without Enhanced Behaviour-Targeted Treatment Support on Adherence and Completion of Treatment for Latent Tuberculosis Infection among Adults in the UK (RID-TB: Treat): Protocol for an Open-Label, Multicentre, Randomised Controlled Trial.” BMJ Open, vol. 12, no. 9, 2022, pp. e057717–e057717.

Chicago Style

Rangaka, MX, Y Hamada, T Duong, et al. 2022. “Evaluating the Effect of Short-Course Rifapentine-Based Regimens with or without Enhanced Behaviour-Targeted Treatment Support on Adherence and Completion of Treatment for Latent Tuberculosis Infection among Adults in the UK (RID-TB: Treat): Protocol for an Open-Label, Multicentre, Randomised Controlled Trial.” BMJ Open 12 (9): e057717–e057717.
Print